在大动物模型中,骨形态发生蛋白-2 和血管内皮生长因子释放时间对异位和原位成骨的影响不同。
A differential effect of bone morphogenetic protein-2 and vascular endothelial growth factor release timing on osteogenesis at ectopic and orthotopic sites in a large-animal model.
机构信息
Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands.
出版信息
Tissue Eng Part A. 2012 Oct;18(19-20):2052-62. doi: 10.1089/ten.TEA.2011.0560. Epub 2012 Sep 12.
In bone tissue engineering, growth factors are widely used. Bone morphogenetic proteins (BMPs) and vascular endothelial growth factor (VEGF) are the most well-known regulators of osteogenesis and angiogenesis. We investigated whether the timing of dual release of VEGF and BMP-2 influences the amount of bone formation in a large-animal model. Poly(lactic-co-glycolic acid) (PLGA) microparticles (MPs) were loaded with BMP-2 or VEGF to create sustained-release profiles, and rapidly degrading gelatin was loaded with either growth factor for fast-release profiles. To study in vivo osteogenicity, the two delivery vehicles were combined with biphasic calcium phosphate (BCP) scaffolds and implanted in 10 Beagle dogs for 9 weeks, at both ectopic (paraspinal muscles) and orthotopic sites (critical-size ulnar defect). The 9 ectopic groups contained combined or single BMP/VEGF dosage, in sustained- or fast-release profiles. In the ulnae of 8 dogs, fast VEGF and sustained BMP-2 were applied to one leg, and the other received the opposite release profiles. The two remaining dogs received bilateral control scaffolds. Bone growth dynamics was analyzed by fluorochrome injection at weeks 3, 5, and 7. Postoperative and posteuthanization X-rays of the ulnar implants were taken. After 9 weeks of implantation, bone quantity and bone growth dynamics were studied by histology, histomorphometry, and fluorescence microscopy. The release of the growth factors resulted in both enhanced orthotopic and ectopic bone formation. Bone formation started before 3 weeks and continued beyond 7 weeks. The ectopic BMP-2 fast groups showed significantly more bone compared to sustained release, independent of the VEGF profile. The ulna implants revealed no significant differences in the amount of bone formed. This study shows that timing of BMP-2 release largely determines speed and amount of ectopic bone formation independent of VEGF release. Furthermore, at the orthotopic site, no significant effect on bone formation was found from a timed release of growth factors, implicating that timed-release effects are location dependent.
在骨组织工程中,生长因子被广泛应用。骨形态发生蛋白(BMPs)和血管内皮生长因子(VEGF)是骨生成和血管生成最著名的调节因子。我们研究了 VEGF 和 BMP-2 的双重释放时间是否会影响大型动物模型中的骨形成量。聚(乳酸-共-乙醇酸)(PLGA)微球(MPs)负载 BMP-2 或 VEGF 以形成持续释放曲线,快速降解的明胶负载生长因子以形成快速释放曲线。为了研究体内成骨能力,将两种输送载体与双相磷酸钙(BCP)支架结合,并在 10 只比格犬中异位(椎旁肌肉)和原位(尺骨临界缺损)植入 9 周。9 个异位组包含了联合或单一 BMP/VEGF 剂量,在持续或快速释放曲线中。在 8 只狗的尺骨中,快速 VEGF 和持续 BMP-2 应用于一条腿,另一条腿接受相反的释放曲线。其余 2 只狗接受双侧对照支架。通过在第 3、5 和 7 周注射荧光染料分析骨生长动力学。对尺骨植入物进行术后和安乐死后 X 射线检查。植入 9 周后,通过组织学、组织形态计量学和荧光显微镜研究骨量和骨生长动力学。生长因子的释放导致了原位和异位骨形成的增强。骨形成在 3 周前开始,并持续到 7 周后。BMP-2 快速释放的异位组与持续释放相比,骨量明显更多,与 VEGF 释放无关。尺骨植入物形成的骨量没有明显差异。这项研究表明,BMP-2 释放的时间很大程度上决定了异位骨形成的速度和量,而与 VEGF 释放无关。此外,在原位部位,从生长因子的定时释放中未发现对骨形成有显著影响,这表明定时释放效应与位置有关。
相似文献
Mater Sci Eng C Mater Biol Appl. 2020-7
引用本文的文献
Nanomedicine (Lond). 2025-2
ACS Biomater Sci Eng. 2023-9-11
Int J Bioprint. 2023-3-8
NPJ Regen Med. 2023-3-13
Nanomaterials (Basel). 2023-2-10
本文引用的文献
Tissue Eng Part B Rev. 2010-11-1
Tissue Eng Part B Rev. 2010-4